South America Travel Vaccines Market Forecast to 2028 – COVID

South America Travel Vaccines Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Hepatitis A, Hepatitis B, Meningococcal Vaccines, and Others) and Application (Domestic Travel and Outbound Travel)

Report Code : BMIRE00025527 | Region : LAMEA | Industry : Pharmaceuticals | Published Date : 10/Aug/2022

The travel vaccines market in SAM is expected to grow from US$ 143.20 million in 2021 to US$ 243.85 million by 2028; it is estimated to grow at a CAGR of 7.6% from 2021 to 2028.

The SAM travel vaccines market is segmented into Brazil, Argentina, and the Rest of SAM. During the forecast period, the region is expected to continue its dominance due to an increase in the prevalence of regional diseases, rapid technological innovations, vaccine development, and an increasing geriatric population. Brazil is the major vaccine manufacturer in the region. The country is self-sufficient for 54% of vaccination needs, including DTP, DT for adults and infants, TT, HepB, and DTP combined vaccines (DTP-HB and DTP-HB-Hib), seasonal influenza vaccine, YF vaccine, and meningo AþC. Brazil is one of the major worldwide producers of the YF vaccine, with the lowest market price. Similar to Brazil, Argentina is also the largest country in the region. Argentina has an upper middle-income economy with a diversified industrial sector. The country’s GDP was US$ 123,369 million in 2021. The GDP of Argentina has grown at a compound rate of 6.8% over the last five years. Major countries contributing to the market's growth include Chile, Colombia, Peru, Cuba, Venezuela, and Bolivia. The countries offer significant growth opportunities for the growth of the market. The factors such as increasing focus on vaccine research, continuous advancements in vaccine development technologies, and increasing government spending on pharmaceutical R&D in the region are expected to boost the travel vaccines market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM travel vaccines market. The SAM travel vaccines market is expected to grow at a good CAGR during the forecast period.

SAM Travel Vaccines Market Revenue and Forecast to 2028 (US$ Million)

SAM Travel Vaccines Market Segmentation

SAM travel vaccines market is segmented into product, application, and country. The SAM travel vaccines market, based on product, is segmented into hepatitis A, hepatitis B, meningococcal vaccines, and others. In 2021, the others segment held the largest share of the market. The SAM travel vaccines market, based on application, is segmented into domestic travel and outbound travel. In 2021, the outbound travel segment held the largest share of the market. Based on country, the SAM travel vaccines market is segmented into Brazil, Argentina, and the Rest of SAM.

Abbott; GlaxoSmithKline plc; Merck & Co., Inc.; Novartis AG; Pfizer Inc.; and Sanofi are among the leading companies in the travel vaccines market in the region.

At 7.6% CAGR, the South America Travel Vaccines market is speculated to be worth US$ 334.25 million by 2028, says The Insight Partners

According to The Insight Partners’ research, the SAM travel vaccines market was valued at US$ 200.44 million in 2021 and is expected to reach US$ 334.25 million by 2028, registering an annual growth rate of 7.6% from 2021 to 2028. The continuous demand for vaccines and increasing cases of new infectious diseases are the critical factors attributed to the market expansion.

Vaccines are essential in providing immunity against infectious diseases. Success stories of eradicating smallpox and polio by vaccines have inspired many researchers and manufacturing companies. In recent times, vaccines have helped control and prevent COVID–19 to a large extent. Moreover, factors such as growing population, SAM travel, underlying mutations of bacteria and virus, and development of new threats that requires rapid solutions are likely to boost the demand for vaccines and expected to flourish the growth of the market during the forecast period.

Despite several manufacturing challenges, vaccine production has increased significantly. The developments in technology have enabled researchers and manufacturing companies to offer potential changes in formulation, production, and development of vaccines. Also, growing developments in the healthcare industries in developing countries have triggered the development and production of vaccines. Such programs are likely to increase the production of vaccines and meet the never-ending demand for immunization in the future.

On the contrary, high cost of travel vaccines hurdles the growth of SAM travel vaccines market.

Based on product, the travel vaccines market sphere segmented into hepatitis A, hepatitis B, meningococcal vaccines, and others. The others segment held 50.0% market share in 2021, amassing US$ 100.31 million. It is projected to garner US$ 165.79 million by 2028 to expand at 7.4% CAGR during 2021–2028.

By application, the SAM travel vaccines market is bifurcated into domestic travel and outbound travel . With 90.6% share of the domain, the outbound travel segment dominated the market in 2021. It accrued US$ 181.64 million in 2021 and is estimated to generate US$ 308.92 million by 2028 to grow at a CAGR of 7.9% over the forecast period.

Our regional analysis states that Brazil captured 71.4% market share in 2021. It was assessed at US$ 143.20 million in 2021 and is likely to hit US$ 243.85 million by 2028, exhibiting a CAGR of 7.9% during the forecast period.

Key players dominating the SAM travel vaccines market are Abbott; GlaxoSmithKline plc; Merck & Co., Inc.; Novartis AG; Pfizer Inc.; and Sanofi among others.

In June 2020, Merck acquired Themis, a privately-held company emphasized on immune-modulation therapies and vaccines for infectious diseases and cancer. As a result of the acquisition, Themis will operate as a wholly-owned subsidiary of Merck. In March 2021, GSK entered into an agreement to supply its rotavirus vaccine, Rotarix, through the Humanitarian Mechanism for civil society organizations. The vaccine was made available at lowest global price for the tube presentation. The agreement builds on GSK’s existing commitment to the Humanitarian Mechanism for its PCV (pneumococcal conjugate vaccine), Synflorix, at the lowest global price for its four dose vial presentation, also supplied to UNICEF.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 SAM Travel Vaccines Market – By Product

1.3.2 SAM Travel Vaccines Market – By Application

1.3.3 SAM Travel Vaccines Market – By Country

2. SAM Travel Vaccines Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. SAM Travel Vaccines Market– Market Landscape

4.1 Overview

4.2 SAM PEST Analysis

4.3 Expert Opinion

5. SAM Travel Vaccines Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Travel and Tourism is Growing

5.1.2 Growing Incidences of Infectious Diseases

5.2 Market Restraints

5.2.1 High Cost of Travel Vaccines

5.3 Market Opportunities

5.3.1 Awareness Regarding Vaccines

5.4 Future Trends

5.4.1 Continuous Ongoing Demand for Vaccines

5.5 Impact Analysis

6. Travel Vaccines Market – SAM Analysis

6.1 SAM Travel Vaccines Marker Revenue Forecast and Analysis

7. SAM Travel Vaccines Market Analysis – By Product

7.1 Overview

7.2 SAM Travel Vaccines Market Revenue Share, by Product (2021 and 2028)

7.3 Hepatitis A

7.3.1 Overview

7.3.2 Hepatitis A: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

7.4 Hepatitis B

7.4.1 Overview

7.4.2 Hepatitis B: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

7.5 Meningococcal Vaccines

7.5.1 Overview

7.5.2 Meningococcal Vaccines: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

8. SAM Travel Vaccines Market Analysis – By Application

8.1 Overview

8.2 SAM Travel Vaccines Market Revenue Share, by Application (2021 and 2028)

8.3 Domestic Travel

8.3.1 Overview

8.3.2 Domestic Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

8.4 Outbound Travel

8.4.1 Overview

8.4.2 Outbound Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

9. SAM Travel Vaccines Market – Country Analysis

9.1 Overview

9.1.1 SAM: Travel Vaccines Market, by Country, 2020 & 2028 (%)

9.1.1.1 Brazil: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.1.1 Brazil: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.1.2 Brazil: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.1.3 Brazil: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

9.1.1.2 Argentina: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.2.1 Argentina: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.2.2 Argentina: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.2.3 Argentina: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

9.1.1.3 Rest of SAM: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.3.1 Rest of SAM: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.3.2 Rest of SAM: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.3.3 Rest of SAM: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

10. Travel Vaccines Market–Industry Landscape

10.1 Overview

10.2 Growth Strategies in the Travel Vaccines Market, (%)

10.3 Organic Developments

10.3.1 Overview

10.4 Inorganic Developments

10.4.1 Overview

11. Company Profiles

11.1 GlaxoSmithKline plc.

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Merck & Co., Inc.

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Sanofi

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Novartis AG

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Pfizer Inc.

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Abbott

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

12. Appendix

12.1 About the Insight Partners

12.2 Glossary of Terms

LIST OF TABLES.

Table 1.             Brazil: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 2.             Brazil: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 3.             Argentina: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 4.             Argentina: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 5.             Rest of SAM: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 6.             Rest of SAM: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 7.             Organic Developments Done by Companies

Table 8.             Inorganic Developments Done by Companies

Table 9.             Glossary of Terms, SAM Travel vaccines Market

LIST OF FIGURES.

Figure 1.           SAM Travel Vaccines Market Segmentation

Figure 2.           SAM Travel Vaccines Market – By Country

Figure 3.           SAM Travel Vaccines Market Overview

Figure 4.           SAM Outbound Segment Held Largest Share of Travel Vaccines Market by Product

Figure 5.           Brazil to Show Significant Growth During Forecast Period

Figure 6.           SAM: PEST Analysis

Figure 7.           Expert Opinion

Figure 8.           SAM Travel Vaccines Market Impact Analysis of Drivers and Restraints

Figure 9.           SAM Travel Vaccines Market – Revenue Forecast and Analysis – 2019 - 2028

Figure 10.        SAM Travel Vaccines Market Revenue Share, by Product (2021 and 2028)

Figure 11.        SAM Hepatitis A: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 12.        SAM Hepatitis B: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 13.        SAM Meningococcal Vaccines: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 14.        SAM Others: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 15.        SAM Travel Vaccines Market Revenue Share, by Application (2021 and 2028)

Figure 16.        SAM Domestic Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17.        SAM Outbound Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18.        SAM: Travel Vaccines Market, by Key Country – Revenue (2021) (US$ Million)

Figure 19.        SAM: Travel Vaccines Market, by Country, 2020 & 2028 (%)

Figure 20.        Brazil: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 21.        Argentina: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 22.        Rest of SAM: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 23.        Growth Strategies in the Travel Vaccines Market, (%)

The List of Companies - South America Travel Vaccines Market

● Abbott

● GlaxoSmithKline plc

● Merck & Co., Inc.

● Novartis AG

● Pfizer Inc.

● Sanofi

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the SAM travel vaccines market

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the SAM travel vaccines market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the travel vaccines market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

TOP